官方APP下载:英语全能特训(微信小程序版,支持苹果手机、安卓手机)
创办于2003年
UNSV记不住?那就记中文谐音“忧安思危”吧!
  Slow and Steady Wins the Race!
UNSV英语学习频道 - Slow and steady wins the race!
公众微信服务号
英语全能特训(微信公众服务号)
UNSV英语学习频道淘宝网店
客服短信:18913948480
客服邮箱:web@unsv.com
初级VIP会员
全站英语学习资料下载。
¥98元/12个月

DEVELOPMENT REPORT - WTO Agreement on Drug Patents

阅读次数:


VIP会员专享下载:(非VIP会员无权下载!如果想下载,但还不是VIP会员,请点此订购
下载方式:使用鼠标右键(注意是鼠标右键!)点击下面的MP3音频/MP4视频链接,然后选择“另存为…”。
PDF节目文稿 PDF节目文稿  MP3节目录音 MP3节目录音 
文章正文
同步字幕

This is the VOA Special English Development Report.

Developing countries won a major victory at the World Trade Organization meeting earlier this month in Doha, Qatar. The battle was over the rights of poor nations to produce life-saving drugs during health emergencies.

More than one-hundred-forty countries attended the Doha conference. The group finally reached an agreement after more than a week of debate. It permits developing countries to give so-called "compulsory licenses" during national health emergencies. A compulsory license requires drug manufacturers to share their inventions with competing companies.

When a drug company develops a cure or treatment for a disease, it seeks special rights to make and sell the product. This special permission is called a patent. A patent prevents other companies from making the same drug for a number of years while the patent is in force.

Under compulsory licenses, other companies are permitted to produce low-cost generic drugs. These are copies of costly medicines patented by large drug companies.

In the past, a lack of understanding existed over the rights of developing countries to give compulsory licenses. However, this issue was settled by the Doha agreement. Developing countries are now able to give compulsory licenses when dealing with public health crises. These include AIDS, malaria, tuberculosis and diseases likely to spread quickly through the population.

Poor countries are not able to pay for costly drugs to treat diseases such as AIDS. So the debate over drug patents is between rich and poor countries. International drug companies in Europe and the United States oppose the Doha agreement. They say it will prevent drug companies from seeking cures for diseases that affect the poor. Drug companies say they are forced to charge high prices for medicines to pay for the high cost of their research. Drug patents are important because they help companies recover money spent developing new medicines.

Developing countries, such as India, Brazil and South Africa, support the Doha agreement. They say poor nations should be able to produce or import less costly generic drugs in times of health crises. They say the goal is to reduce the cost of drugs to treat diseases that kill millions of poor people every year.

This VOA Special English Development Report was written by Jill Moss.

网友的学习评论(0条):
版权所有©2003-2019 南京通享科技有限公司,保留所有权利。未经书面许可,严禁转载本站内容,违者追究法律责任。 互联网经营ICP证:苏B2-20120186
网站备案:苏ICP备05000269号-1中国工业和信息化部网站备案查询
广播台